| Dr Monika Onusseit, PHARMD | |
|
189 Prouty Dr, Newport, VT 05855-9326 | |
| (802) 334-7331 | |
| (802) 334-3204 |
| Full Name | Dr Monika Onusseit |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 189 Prouty Dr, Newport, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548600398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0093793 (Vermont) | Primary |
| 183500000X | Pharmacist | PH234346 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Monika Onusseit, PHARMD Po Box 168, Newport, VT 05855-0168 Ph: () - | Dr Monika Onusseit, PHARMD 189 Prouty Dr, Newport, VT 05855-9326 Ph: (802) 334-7331 |
News Archive
Various human nervous system diseases, such as amyotrophic lateral sclerosis (ALS), Alzheimer's, Huntington's, and Parkinson's diseases, are associated with the same basic disorder: the loss of nerve cells capacity to fold their proteins correctly, which causes protein aggregations that form "clumps" that end up generating the cell death.
Marking the launch of its newly redesigned Web site, Informatics Corporation of America (ICA; www.icainformatics.com), provider of electronic solutions to hospitals, integrated delivery networks (IDNs), and health information exchanges (HIEs), announces the availability of an informative white paper, "Health Care IT Investment Heightens Need For Effective Implementation: Introducing five key elements for successful roll-out of clinical information systems (CIS)," http://www.icainformatics.com/news-and-events/white-papers/.
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment.
Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs.
An 18-year follow-up study of postmenopausal women in the Women's Health Initiative trials has shown that the use of hormone therapy was not associated with any increased risk of all-cause, cardiovascular or cancer death.
› Verified 9 days ago
Melissa Frizzell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Shattuck Hill Rd, Newport, VT 05855 Phone: 802-334-1600 | |
Juana Elizabeth Tejada Pichette, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Waterfront Plaza, Newport, VT 05855 Phone: 802-808-0000 | |
Bryan A Dellaria, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Waterfront Plz, Ste 2, Newport, VT 05855 Phone: 802-334-6785 | |
Dr. Lauren Hannemann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Waterfront Plz, Newport, VT 05855 Phone: 802-334-6785 Fax: 802-334-2298 | |
Mrs. Elaine Marie Nicol-cashin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Waterfront Plaza, Newport, VT 05855 Phone: 802-334-6785 | |
Christine A Seipel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Prouty Dr, Newport, VT 05855 Phone: 802-334-7331 Fax: 802-334-3204 | |
Michael A Omar, B.S., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Prouty Dr, Newport, VT 05855 Phone: 802-334-7331 Fax: 802-334-3204 |